The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53

Anna Stengel1, Wolfgang Kern1, Torsten Haferlach1

  • 1MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, 81377, Germany.